Fig. 1.

Recurrence-free survival among patients receiving <6 cycles of chemotherapy versus those receiving 6 cycles of chemotherapy.

Recurrence-free survival among patients receiving <6 cycles of chemotherapy versus those receiving 6 cycles of chemotherapy.